VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q83610012  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000221.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q83610012‏
024 ‎‡a  0000-0002-4579-9202‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q83610012‏
100 0 ‎‡a  C-H Zhang‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  C-H Zhang‏ ‎‡c  onderzoeker‏ ‎‡9  nl‏
670 ‎‡a  Author's Discovery and structure-activity analysis of 4-((5-nitropyrimidin-4-yl)amino)benzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors‏
670 ‎‡a  Author's Discovery of 6-phenylimidazo[2,1-b]thiazole derivatives as a new type of FLT3 inhibitors‏
670 ‎‡a  Author's Discovery of KDM5A inhibitors: Homology modeling, virtual screening and structure-activity relationship analysis‏
670 ‎‡a  Author's Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivo.‏
670 ‎‡a  Author's Preclinical Evaluation of a Novel Orally Available SRC/Raf/VEGFR2 Inhibitor, SKLB646, in the Treatment of Triple-Negative Breast Cancer‏
670 ‎‡a  Author's Progress of small molecular inhibitors in the development of anti-influenza virus agents‏
670 ‎‡a  Author's Retrieving novel C5aR antagonists using a hybrid ligand-based virtual screening protocol based on SVM classification and pharmacophore models.‏
670 ‎‡a  Author's SKLB1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl, displays exceptional activity in models of FLT3-driven AML and considerable potency in models of CML harboring Abl mutants.‏
670 ‎‡a  Author's Structural modification of an EGFR inhibitor that showed weak off-target activity against RET leading to the discovery of a potent RET inhibitor‏
670 ‎‡a  Author's Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine derivatives, a new class of reversible kinase inhibitors targeting both EGFR-activating and resistance mutations.‏
909 ‎‡a  (orcid) 0000000245799202‏ ‎‡9  1‏
919 ‎‡a  structuralmodificationofanegfrinhibitorthatshowedweakofftargetactivityagainstretleadingtothediscoveryofapotentretinhibitor‏ ‎‡A  Structural modification of an EGFR inhibitor that showed weak off-target activity against RET leading to the discovery of a potent RET inhibitor‏ ‎‡9  1‏
919 ‎‡a  structuraloptimizationandstructureactivityrelationshipsofn244methylpiperazin1ylphenyln8phenyl9hpurine28diaminederivativesanewclassofreversiblekinaseinhibitorstargetingbothegfractivatingandresistancemutations‏ ‎‡A  Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine derivatives, a new class of reversible kinase inhibitors targeting both EGFR-activating and resistance mutations.‏ ‎‡9  1‏
919 ‎‡a  discoveryofkdm5ainhibitorshomologymodelingvirtualscreeningandstructureactivityrelationshipanalysis‏ ‎‡A  Discovery of KDM5A inhibitors: Homology modeling, virtual screening and structure-activity relationship analysis‏ ‎‡9  1‏
919 ‎‡a  discoveryof6phenylimidazothiazolederivativesasanewtypeofflt3inhibitors‏ ‎‡A  Discovery of 6-phenylimidazo[2,1-b]thiazole derivatives as a new type of FLT3 inhibitors‏ ‎‡9  1‏
919 ‎‡a  discoveryandstructureactivityanalysisof45nitropyrimidin4ylaminobenzimidamidederivativesasnovelproteinargininemethyltransferase1prmt1inhibitors‏ ‎‡A  Discovery and structure-activity analysis of 4-((5-nitropyrimidin-4-yl)amino)benzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors‏ ‎‡9  1‏
919 ‎‡a  discoveryofthenovelpotentandselectiveflt3inhibitor15thiadiazol2yl3ptolylureaanditsantiacutemyeloidleukemiaamlactivitiesinvitroandinvivo‏ ‎‡A  Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivo.‏ ‎‡9  1‏
919 ‎‡a  preclinicalevaluationofanovelorallyavailablesrcrafvegfr2inhibitorsklb646inthetreatmentoftriplenegativebreastcancer‏ ‎‡A  Preclinical Evaluation of a Novel Orally Available SRC/Raf/VEGFR2 Inhibitor, SKLB646, in the Treatment of Triple-Negative Breast Cancer‏ ‎‡9  1‏
919 ‎‡a  progressofsmallmolecularinhibitorsinthedevelopmentofantiinfluenzavirusagents‏ ‎‡A  Progress of small molecular inhibitors in the development of anti-influenza virus agents‏ ‎‡9  1‏
919 ‎‡a  retrievingnovelc5arantagonistsusingahybridligandbasedvirtualscreeningprotocolbasedonsvmclassificationandpharmacophoremodels‏ ‎‡A  Retrieving novel C5aR antagonists using a hybrid ligand-based virtual screening protocol based on SVM classification and pharmacophore models.‏ ‎‡9  1‏
919 ‎‡a  sklb1028anoveloralmultikinaseinhibitorofegfrflt3andabldisplaysexceptionalactivityinmodelsofflt3drivenamlandconsiderablepotencyinmodelsof950harboringablmutants‏ ‎‡A  SKLB1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl, displays exceptional activity in models of FLT3-driven AML and considerable potency in models of CML harboring Abl mutants.‏ ‎‡9  1‏
996 ‎‡2  LC|n 2016057317‏
996 ‎‡2  ISNI|0000000052947838‏
996 ‎‡2  J9U|987010000206705171‏
996 ‎‡2  NTA|121727432‏
996 ‎‡2  ISNI|000000006417641X‏
996 ‎‡2  DNB|128891377X‏
996 ‎‡2  ISNI|0000000044053164‏
996 ‎‡2  LC|nb2014012185‏
996 ‎‡2  LC|n 83199255‏
996 ‎‡2  DNB|1222116111‏
996 ‎‡2  LC|no2009079511‏
996 ‎‡2  ISNI|0000000138974087‏
996 ‎‡2  LC|no 89005893‏
996 ‎‡2  NTA|147708087‏
996 ‎‡2  ISNI|0000000382478640‏
996 ‎‡2  LC|n 2003064769‏
996 ‎‡2  DNB|1196832161‏
996 ‎‡2  DNB|1293512036‏
996 ‎‡2  CYT|AC000415039‏
996 ‎‡2  ISNI|0000000063452670‏
996 ‎‡2  ISNI|0000000053981704‏
996 ‎‡2  DNB|131936530‏
996 ‎‡2  SUDOC|254496113‏
996 ‎‡2  ISNI|0000000063781992‏
996 ‎‡2  CYT|AC000096150‏
996 ‎‡2  NII|DA09446767‏
996 ‎‡2  ISNI|0000000120490295‏
996 ‎‡2  PLWABN|9813178109205606‏
996 ‎‡2  DNB|1100570993‏
996 ‎‡2  SUDOC|259378380‏
996 ‎‡2  LC|nr 90010760‏
996 ‎‡2  ISNI|0000000382261505‏
996 ‎‡2  BNF|16207921‏
996 ‎‡2  LC|n 97109567‏
996 ‎‡2  DNB|1206349913‏
996 ‎‡2  LC|no2023026879‏
996 ‎‡2  LC|no2022155248‏
996 ‎‡2  DNB|1016388322‏
996 ‎‡2  DNB|1228577390‏
996 ‎‡2  ISNI|0000000047042911‏
996 ‎‡2  CYT|AC000286918‏
996 ‎‡2  ISNI|0000000064215650‏
996 ‎‡2  DNB|1089655398‏
996 ‎‡2  CYT|AC000073020‏
996 ‎‡2  BNF|15783889‏
996 ‎‡2  DNB|1290294402‏
996 ‎‡2  LC|n 2015039625‏
996 ‎‡2  ISNI|0000000064195143‏
996 ‎‡2  ISNI|0000000063360039‏
996 ‎‡2  BIBSYS|90411934‏
996 ‎‡2  SUDOC|157874354‏
996 ‎‡2  SUDOC|240786904‏
996 ‎‡2  NII|DA17105193‏
996 ‎‡2  LC|n 2021037017‏
996 ‎‡2  RERO|A017351696‏
996 ‎‡2  LC|no2016158422‏
996 ‎‡2  LC|n 79098742‏
996 ‎‡2  DNB|1282194135‏
996 ‎‡2  BNF|16027579‏
996 ‎‡2  ISNI|0000000081839246‏
996 ‎‡2  ISNI|0000000109067648‏
996 ‎‡2  DNB|1078162298‏
996 ‎‡2  ISNI|0000000047187555‏
996 ‎‡2  CYT|AC000110327‏
996 ‎‡2  NUKAT|n 95301961‏
996 ‎‡2  LNB|LNC10-000233098‏
996 ‎‡2  CYT|AC000434949‏
996 ‎‡2  DNB|121137114X‏
996 ‎‡2  DNB|1167430565‏
996 ‎‡2  BIBSYS|97052162‏
996 ‎‡2  ISNI|0000000047743283‏
996 ‎‡2  ISNI|0000000403247981‏
996 ‎‡2  DNB|1128673614‏
996 ‎‡2  DNB|133078019‏
996 ‎‡2  DNB|1152225456‏
996 ‎‡2  ISNI|0000000064313058‏
996 ‎‡2  LC|no2014104841‏
996 ‎‡2  LC|no2008047400‏
996 ‎‡2  ISNI|0000000409339406‏
996 ‎‡2  DNB|123854519X‏
996 ‎‡2  LC|no2001090512‏
996 ‎‡2  ISNI|0000000084516733‏
996 ‎‡2  CYT|AC000304949‏
996 ‎‡2  J9U|987007461898105171‏
996 ‎‡2  LC|nr2002017485‏
996 ‎‡2  ISNI|0000000513273101‏
996 ‎‡2  RERO|A011123164‏
996 ‎‡2  ISNI|0000000115412866‏
996 ‎‡2  DNB|1084587726‏
996 ‎‡2  LC|n 88177966‏
996 ‎‡2  CYT|AC000661530‏
996 ‎‡2  DNB|1085646165‏
996 ‎‡2  DNB|1248082605‏
996 ‎‡2  ISNI|0000000047591590‏
996 ‎‡2  DNB|1191908658‏
996 ‎‡2  DNB|1176221043‏
996 ‎‡2  DNB|126611825X‏
996 ‎‡2  LC|nr 94011413‏
996 ‎‡2  ISNI|0000000448022452‏
996 ‎‡2  CYT|AC000635740‏
996 ‎‡2  CAOONL|ncf12121519‏
996 ‎‡2  ISNI|0000000108951087‏
996 ‎‡2  DNB|1277012261‏
996 ‎‡2  ISNI|0000000063394191‏
996 ‎‡2  NTA|238684644‏
996 ‎‡2  ISNI|0000000114884394‏
996 ‎‡2  ISNI|0000000045242813‏
996 ‎‡2  SUDOC|143797662‏
996 ‎‡2  LC|n 2020021651‏
996 ‎‡2  LC|n 2009079694‏
996 ‎‡2  NDL|033392273‏
996 ‎‡2  DNB|1243695005‏
996 ‎‡2  SUDOC|260006688‏
996 ‎‡2  CYT|AC000521323‏
996 ‎‡2  LC|n 2015032702‏
996 ‎‡2  LC|n 2015032701‏
996 ‎‡2  ISNI|0000000073197984‏
996 ‎‡2  LC|n 2015182378‏
996 ‎‡2  SUDOC|03462399X‏
996 ‎‡2  DNB|130029387X‏
996 ‎‡2  ERRR|12368167‏
996 ‎‡2  ISNI|0000000064221735‏
996 ‎‡2  CYT|AC000110739‏
996 ‎‡2  LC|n 2011025412‏
996 ‎‡2  DNB|1237862167‏
996 ‎‡2  LC|n 2018182349‏
996 ‎‡2  LC|no2021046967‏
996 ‎‡2  NSK|000566343‏
996 ‎‡2  LC|no2011083922‏
996 ‎‡2  LC|no2011083927‏
996 ‎‡2  NII|DA19208550‏
996 ‎‡2  ISNI|0000000025531415‏
996 ‎‡2  DNB|114899453X‏
996 ‎‡2  SUDOC|180108603‏
996 ‎‡2  CAOONL|ncf10530312‏
996 ‎‡2  LC|no2018031567‏
996 ‎‡2  BNF|13747100‏
996 ‎‡2  DNB|141180889‏
996 ‎‡2  BNF|17860481‏
996 ‎‡2  NYNYRILM|385679‏
996 ‎‡2  LC|n 87939262‏
996 ‎‡2  LC|n 2003059288‏
996 ‎‡2  DNB|1253686750‏
996 ‎‡2  NUKAT|n 2020143135‏
996 ‎‡2  ISNI|0000000063828076‏
996 ‎‡2  NII|DA12115950‏
996 ‎‡2  LC|nr 96005657‏
996 ‎‡2  DNB|125322255X‏
996 ‎‡2  NTA|169256464‏
996 ‎‡2  LC|no2011197361‏
996 ‎‡2  DNB|1130183076‏
996 ‎‡2  B2Q|0000136586‏
996 ‎‡2  LC|nr 00039098‏
996 ‎‡2  ISNI|0000000120051663‏
996 ‎‡2  ISNI|0000000045962597‏
996 ‎‡2  ISNI|0000000080708930‏
996 ‎‡2  KRNLK|KAC200612118‏
996 ‎‡2  BIBSYS|9078111‏
996 ‎‡2  NII|DA18255511‏
996 ‎‡2  NII|DA02876473‏
996 ‎‡2  NTA|146262069‏
996 ‎‡2  CYT|AC000340704‏
996 ‎‡2  CYT|AC000656300‏
996 ‎‡2  ISNI|0000000063337306‏
996 ‎‡2  CYT|AC000317190‏
996 ‎‡2  DNB|1317568427‏
996 ‎‡2  DNB|132360616‏
996 ‎‡2  ISNI|0000000064093286‏
996 ‎‡2  DNB|1137518065‏
996 ‎‡2  LC|n 2021042629‏
996 ‎‡2  ISNI|0000000063404310‏
996 ‎‡2  LC|nb2011010841‏
996 ‎‡2  ISNI|0000000048367603‏
996 ‎‡2  LC|n 84220940‏
996 ‎‡2  LC|no2011070418‏
996 ‎‡2  CYT|AC000638660‏
996 ‎‡2  DNB|1152270869‏
996 ‎‡2  DNB|1252469993‏
996 ‎‡2  CAOONL|ncf11518275‏
996 ‎‡2  ISNI|0000000100460304‏
996 ‎‡2  ISNI|0000000361172888‏
996 ‎‡2  DNB|1314927094‏
996 ‎‡2  LC|n 2011012640‏
996 ‎‡2  ISNI|0000000044377134‏
996 ‎‡2  CAOONL|ncf11070068‏
996 ‎‡2  LC|n 2017025132‏
996 ‎‡2  DNB|1012850447‏
996 ‎‡2  SUDOC|197723675‏
996 ‎‡2  ISNI|0000000437871395‏
996 ‎‡2  DNB|1022363069‏
996 ‎‡2  SUDOC|150560842‏
996 ‎‡2  ISNI|0000000440089222‏
996 ‎‡2  LC|n 2003109515‏
996 ‎‡2  LC|n 2012011469‏
996 ‎‡2  SUDOC|193536285‏
996 ‎‡2  LC|no2021143664‏
996 ‎‡2  PLWABN|9813298726005606‏
996 ‎‡2  DNB|1332784615‏
996 ‎‡2  LC|n 82138411‏
996 ‎‡2  CYT|AC000636401‏
996 ‎‡2  KRNLK|KAC200412654‏
996 ‎‡2  CYT|AC000595092‏
996 ‎‡2  NUKAT|n 2018152144‏
996 ‎‡2  SUDOC|163857024‏
996 ‎‡2  LC|n 2004155141‏
996 ‎‡2  ISNI|0000000444589785‏
996 ‎‡2  DNB|1047865866‏
996 ‎‡2  ISNI|0000000112724733‏
996 ‎‡2  NTA|357297962‏
996 ‎‡2  NSK|000548116‏
996 ‎‡2  LC|no2007111662‏
996 ‎‡2  CYT|AC000134359‏
996 ‎‡2  ISNI|0000000033967980‏
996 ‎‡2  PLWABN|9810538875705606‏
996 ‎‡2  ISNI|000000037589526X‏
996 ‎‡2  NTA|173981747‏
996 ‎‡2  ISNI|0000000063486686‏
996 ‎‡2  ISNI|0000000064176698‏
996 ‎‡2  RERO|A024805009‏
996 ‎‡2  CYT|AC000166922‏
996 ‎‡2  LC|nr 93050264‏
996 ‎‡2  ISNI|0000000357043506‏
996 ‎‡2  LC|n 2016015905‏
996 ‎‡2  CYT|AC000649453‏
996 ‎‡2  SUDOC|131470558‏
996 ‎‡2  DNB|172610036‏
996 ‎‡2  ISNI|000000003791523X‏
996 ‎‡2  LC|no2024067116‏
996 ‎‡2  CYT|AC000475092‏
996 ‎‡2  CYT|AC000375441‏
996 ‎‡2  ISNI|000000011555563X‏
996 ‎‡2  CYT|AC000186829‏
996 ‎‡2  ISNI|0000000029292079‏
996 ‎‡2  DNB|1237924286‏
996 ‎‡2  DNB|171897927‏
996 ‎‡2  DNB|128062857X‏
996 ‎‡2  LC|nr 93038918‏
996 ‎‡2  LC|no2012143290‏
996 ‎‡2  DNB|1212462335‏
996 ‎‡2  LC|no2001072344‏
996 ‎‡2  ISNI|0000000075394340‏
996 ‎‡2  BNF|16897489‏
996 ‎‡2  DNB|130639583‏
996 ‎‡2  DNB|123943485‏
996 ‎‡2  ISNI|0000000458364210‏
996 ‎‡2  LC|n 2011086958‏
996 ‎‡2  NDL|00485790‏
996 ‎‡2  NTA|393855562‏
996 ‎‡2  LC|n 2006071538‏
996 ‎‡2  BNF|14446317‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏